Imbalance of the interleukin 1 system in colonic mucosa - Association with intestinal inflammation and interleukin 1 receptor agonist genotype 2

Gut

Volumn 41, Issue 5, 1997, Pages 651-657

  Andus, T ^a   Daig, R ^a   Vogl, D ^a   Aschenbrenner, E ^a   Lock, G ^a   Hollerbach, S ^a   Kollinger M ^a   Scholmerich J ^a   Gross, V ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Crohn's disease; Genotype; Inflammatory bowel disease; Interleukin 1; Interleukin 1 receptor antagonist; Mucosal inflammation

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0030695989     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.41.5.651     Document Type: Article

References (14)

1. Whelan G. Epidemiology of inflammatory bowel disease. Med Clin North Am 1990; 74: 1-12.
2. Hellers G, Bernell O. Genetic aspects of inflammatory bowel disease. Med Clin North Am 1990; 74: 13-9.
3. Orholm M, Iselius L, Sorensen TI, Munkholm P, Langholz E, Binder V. Investigation of inheritance of chronic inflam-matory bowel diseases by complex segregation analysis. BMJ 1993; 306: 20-4.
4. Bioque G, Crusius JB, Koutroubakis I, Bouma G, Kostense PJ, Meuwissen SG, Pena AS. Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol 1995; 102: 379-83.
5. Hugot J-P, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Groupe d'Etude Thérapeutique des Affection Inflammatoires Digestives. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996; 379: 821-3.
6. Mansfield JC, Holden H, Tarlow JK, Di Giovine FS, McDowell TL, Wilson AG, et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106: 637-42.
7. Dinarello CA, Wolff SM. The role of interleukin-1 in disease [published erratum appears in N Engl J Med 1993 328: 744]. N Engl J Med 1993; 328: 106-13.
8. Arend WP. Interleukin-1 receptor antagonist. Adv Immunol 1993; 54: 167-227.
9. Lennard AC. Interleukin-1 receptor antagonist. Crit Rev Immunol 1995; 15: 77-105.
10. Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease - enhanced production during active disease. Gut 1990; 31: 686-9.
11. Brynskov J, Tvede N, Andersen CB, Vilien M. Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. Gut 1992; 33: 55-8.
12. Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, Muggia A, a al. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 1992; 37: 818-26.
13. Isaacs KL, Sartor RB, Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992; 103: 1587-95.
14. Cappello M, Keshav S, Prince C, Jewell DP, Gordon S. Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation. Gut 1992; 33: 1214-9.